Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Immunity 48 , 313326.e5 (2018)
Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver
However, significant individual variation exists based on factors such as: Body composition and weight distribution volume may differ Metabolic rate affects how quickly proteins are broken down Dose and duration of treatment higher doses and longer treatment may extend elimination time Individual patient factors age, overall health status, and concurrent medications Patients who have been taking Wegovy at the full 2.4 mg maintenance dose should expect the medication to remain active in their system for several weeks after discontinuation
This advice can assist them in making smart choices and understanding possible side effects
